(1). Non-immunocompromised patients may occasionally develop PcP (2). Low levels of
48
Pneumocystis DNA can be detected in respiratory samples from subjects without signs and 49 symptoms of PcP; this is known as "colonization", "carriage", "subclinical infection" or these samples is difficult in infants and toddlers. Therefore, non-invasive sampling such as 56 collection of nasopharyngeal (NP) swabs is highly useful for this population (6).
57
The mitochondrial large subunit (mtLSU) rRNA gene is a commonly used target for P.
58
jirovecii diagnosis and quantification (7). This gene is also useful for molecular 59 epidemiology studies and determination of population genetic structure (7, 8) .
60
Dihydropteroate synthase (DHPS) is the target of sulfonamides, the first-line drugs for PcP 61 prophylaxis or treatment. Mutations in the DHPS locus may be a consequence of exposure 62 to sulfonamide drugs and may be related to the emergence of resistant strains of P. jirovecii 63 to these agents (9). Both loci, mtLSU rRNA and DHPS, have been used to identify human 64 reservoirs of this microorganism (7, 9). California, USA). The primers were βac1 (5'-CCT TCC TGG GCA TGG AGT CCT G-3') 119 and βac2 (5'-GGA GCA ATG ATC TTG ATC TTC-3') described by Ghossein et al. (16) .
120
To avoid contamination, each step (master mix preparation, DNA extraction, amplification 19%) . Mixed genotypes were detected in five samples (10%) ( Table 2) .
186
Other nucleotide mutations were detected in several strains. Mutations in positions 123 (C 187 to T), 252 (A to T) and 258 (A to T) were observed ( to high sensitivity and since these provide the possibility of strain identification, 215 quantification and genotyping using non-invasive samples as described in this report.
216
During Pneumocystis colonization there are low levels of fungal DNA in the host. 
229
The mtLSU rRNA gene is involved in basic metabolic functions and has been widely used
230
for PCR-based detection of P. jirovecii and for discerning associations between specific 231 genotypes and geographical locations (6, 17, 19, 27) .
232
In the present study, genotype 2 (85A/248C) was the most frequent genotype (48%) infection. However, this interpretation requires confirmation from other studies.
263
The demonstration of nucleotide changes (without polymorphic positions 85 and 248) in been associated with previous sulfa drug exposition (9, 41 contribute to the differences in the use and effect of sulfonamides for PcP prophylaxis and 296 treatment of bacterial diseases (9, 35, 45, 46 
